IMBCR is dedicated to advance the treatment of myeloma by connecting possibility through scientific innovation leading to personalized and continuous optimized patient care.
Patient-Reported Symptoms via Mobile App May Help Expedite GVHD Identification, Treatment
Telehealth-Based Exercise Program Is Viable Option in Cancer Symptom Management
Cilta-cel Produces MRD Negativity, Responses in Relapsed/Refractory Multiple Myeloma
4 Strategies to Reduce Oncology Nurse Burnout, Stop ‘Silent Quitting’